Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The…more
Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The…more
Latest RNS from Uniphar plc
Analyst consensus: Buy
As of 21 Jul 2026, 3 analysts rate Uniphar plc a Buy, with 67% buy ratings and a mean price target of 415p (range 369p–466p), +8% vs the current price.
Valuation vs peers
Peer-relative fair value estimate: 550p against a current price of 376p (+46%), based on EV/EBITDA.